Nadege Fils-Aime
Overview
Explore the profile of Nadege Fils-Aime including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee-Baggley D, Fils-Aime N, Audet I, Barakat M
Clin Obes
. 2023 Oct;
14(1):e12624.
PMID: 37846529
In this study, we sought to analyse experiences in weight management among physicians working in the area of obesity and contrast these experiences with best practices. By understanding experiences of...
2.
le Roux C, Fils-Aime N, Camacho F, Gould E, Barakat M
EClinicalMedicine
. 2022 Jun;
49:101436.
PMID: 35747175
Background: Extended-release (ER) naltrexone/bupropion (NB) was associated with greater weight loss than placebo in four randomized, 56-week trials. The association of NB with longer-term maintenance of weight loss remains unknown....
3.
Goldenberg R, Bell A, Cheng W, Fils-Aime N, Burrows M, Blavignac J, et al.
Diabetes Res Clin Pract
. 2020 Sep;
170:108416.
PMID: 32891688
Aims: The CV-CARE registry provides RWE in Canadian routine clinical practice. Methods: CV-CARE is a multi-site, observational, prospective Canadian registry enrolling patients initiating treatment with metformin hydrochloride extended-release (MetER) for...
4.
Goldenberg R, Bell A, Cheng W, Paron E, Fils-Aime N, Burrows M, et al.
J Cardiol
. 2020 Jun;
76(4):385-394.
PMID: 32473770
Background: Regional differences in the profile and treatment strategies of patients with cardiometabolic diseases have been studied in several different countries. The Cardio-Vascular and metabolic treatments in Canada: Assessment of...
5.
Dai M, Al-Odaini A, Fils-Aime N, Villatoro M, Guo J, Arakelian A, et al.
Breast Cancer Res
. 2017 Mar;
19(1):43.
PMID: 28351372
No abstract available.
6.
Dai M, Zhang C, Ali A, Hong X, Tian J, Lo C, et al.
Sci Rep
. 2016 Oct;
6:35383.
PMID: 27759034
Triple negative breast cancers exhibit very aggressive features and poor patient outcomes. These tumors are enriched in cancer stem cells and exhibit resistance to most treatments and chemotherapy. In this...
7.
Guo J, Canaff L, Rajadurai C, Fils-Aime N, Tian J, Dai M, et al.
Breast Cancer Res
. 2014 Dec;
16(6):476.
PMID: 25499443
Introduction: This study helps to define the implications of breast cancer anti-estrogen resistance 3 (BCAR3) in breast cancer and extends the current understanding of its molecular mechanism of action. BCAR3...
8.
Garic D, Humbert L, Fils-Aime N, Korah J, Zarfabian Y, Lebrun J, et al.
Anal Biochem
. 2013 Jul;
441(2):182-4.
PMID: 23872007
Western blot is an extensively used method for protein detection in cell biology. To optimize this procedure, here we examined a panel of buffers for their ability to efficiently transfer...
9.
Dai M, Al-Odaini A, Fils-Aime N, Villatoro M, Guo J, Arakelian A, et al.
Breast Cancer Res
. 2013 Jun;
15(3):R49.
PMID: 23786849
Introduction: Deregulation of the cell cycle machinery is often found in human cancers. Modulations in the cell cycle regulator function and expression result not only in proliferative advantages, but also...
10.
Fils-Aime N, Dai M, Guo J, El-Mousawi M, Kahramangil B, Neel J, et al.
J Biol Chem
. 2013 Mar;
288(17):11807-23.
PMID: 23479725
TGF-β plays an important role in breast cancer progression as a prometastatic factor, notably through enhancement of cell migration. It is becoming clear that microRNAs, a new class of small...